novo nordisk is cutting prices on its popular glp-1 drugs. Novo, Lilly Shares Drop as Trump Promises $150 Ozempic Trump says agreement reached with
Description
Management of type 2 diabetes: the role of incretin mimetics
doi: 10.1210/jc.2006-0587
Wolfgang Marik: declares no conflict of interest relevant to this study
In HFpEF and HFmrEF, these drugs are also widely used, but their effect on clinical outcomes such as survival and hospitalisation is limited
Campo pioneered research in this field, discovering in the early 1930s that a class of peptides called 'incretins' could promote - cells' insulin release, promoting blood-sugar metabolism, appetite regulation, and subsequent weight loss
& Mitnik, O
